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Summary: 1-0-Alkyl dihydroxyacetone phosphate is biosynthesised in guinea pig 
liver mitochondria and in rat brain microsomes by direct reaction of a long 
chain alcohol and acyl dihydroxyacetone phosphate. ATP and Mg* are stimula- 
tory but coenzyme A is not necessary for the reaction. 
1-0-Alkyl dihydroxyacetone phosphate (alkyl DHAP)l was shown to be bio- 
synthesized from long chain alcohol and DHAP with ATP, CoA, Mg -I+ and NaF as 
necessary cofactors (1,2). The requirement of CoA was surprising because the 
formation of a thioester intermediate could not easily be envisioned. Various 
preincubation and kinetic studies indicated that an intermediate containing 
DHAP was a precursor of alkyl DHAP (3). In this report evidence is presented 
that acyl DHAP, a lipid known to be formed in the same preparations that can 
form alkyl ethers, reacts with the long chain alcohol to form alkyl DHAP. CoA 
is needed only for the formation of acyl DHAP from endogenous fatty acid (4). 
Formation of acyl DHAP in the alkyl DHAP synthesizing enzyme systems has 
already been reported (1). 
MATERIALS AND METHODS 
l-C14-Hexadecanol was prepared by reducing the methyl ester of 1-C 14 - 
palmitate by RED-Al [sodium bis (2-methoxy ethoxy)-aluminum hydride, Aldrich, 
Milwaukee, Wise.]. 32 P-Labeled palmitoyl DHAP was prepared biosynthetically by 
incubating palmitate and 32 P-DHAP with guinea pig liver mitochondria and 
necessary cofactors (4). The labeled lipid was purified by chromatography on 
silicic acid. 32 P-Acyl GP was prepared by reducing 32 P-acyl DHAP with NaBH4 
1 Abbreviations used: DHAP - dihydroxyacetone phosphate; GP - glycerol-3- 
phosphate. 
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in ethanol. Unlabeled palmitoyl DHAP was chemically synthesized (5). l-O- 
Hexadecoxy DHAP was chemically synthesized from chimyl alcohol as outlined 
below. Chimyl alcohol is oxidized by a mixture of NaI04 and KM&4 (6) to 2- 
hexadecoxy glycolic acid which is converted to 1-hexadecoxy diazoacetone by 
condensing the acid chloride with diazomethane (5). Hexadecoxy DHAP was 
obtained by decomposing the diazo compound with H3P04 (5). 
Guinea pig liver mitochondria were frozen and thawed and the particulate 
residue was washed with 0.25 M sucrose. Young rat (18 days old) brain micro- 
somal fraction was prepared by differential centrifugation (18,000xg - 
lOO,OOOxg, 60 min) and was washed once with 0.25 M sucrose. The lipid emul- 
sions (long chain alcohol, acyl DHAP, etc.) were made by drying down the lipids 
and emulsifier (Triton-X-100) together and then dispersing the dried residue in 
dilute (0.05 M) Tris buffer, and incubating as described in Table 1. The incu- 
bation was stopped by adding 4.5 ml of CHC$-methanol (1:2) then 1.5 ml of 2 M 
KC1 containing H3P04 (0.2 M) and 1.5 ml of additional CHC18 (7,8) were added. 
After mixing and centrifuging, an aliquot of the lower layer was dried and the 
radioactivity in the 32 P-labeled alkali-stable lipid was determined as 
described previously (1). When 14 C-labeled hexadecanol was used as the 
precursor, the 14 C-labeled alkyl DHAP was separated from the radioactive 
precursors and other products by column and thin layer chromatography. After 
alkaline methanolysis (l), the lipid was put on a 6 cm x 0.5 cm silicic acid 
column (Unisil, Clarkson Chemical Co., Pa.) with 0.1 - 0.2 mg of carrier non- 
radioactive synthetic alkyl DHAP. The neutral lipids were eluted with 10 ml 
of CHC13 and the alkyl DHAP was eluted out with 10 ml of CHC13-methanol (4:l). 
The second fraction was dried and an aliquot was applied to a commercial, 
precoated, thin layer plate (E. Merck, Darmstadt, obtained through Brinkmann, 
N.Y.) and the radioactivity in the alkyl DHAP spot was determined after 
development with acetic acid containing solvents with or without bisulfite 
(9,lO). Other methods and materials were as described before (1,4,5,10). 
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Table 1. Requirements for the formation of alkali-stable radioactive lipid 
from 32P-DHAP or 32P-palmitoyl DHAP in liver mitochondria or brain microsomes. 
The whole system contained Tris-HCl (pH 7.4, 50 mM), ATP (8.6 mM), NaF 
(8.6 mM), MgC12 (4.3 mM), CoASH (87 PM), glutathione (4.3 mM), hexadecanol 
(50 pg emulsified by 50 ug Triton-X-100) and enzyme containing 1 mg of 
protein in a total volume of 1.2 ml. The radioactive substrates added are: 
palmitoyl 32P-DHAP or 32P-DHAP or 32P-acyl GP (each 3 nmoles, 105,000 cpm). 
The tubes were incubated at 37" for 30 min and the radioactivity in the 










32 P-a-acyl GPt 
Liver mitochondria Brain microsomes 
From 32P- From 32P- From 32P- From 32P- 
acyl DHAP DHAP acyl DHAP DHAP 
Radioactivity in alkali-stable lipid 
=pm cw cpm cpm 
15,000 780 8,200 410 
3,800 32 4,200 24 
23,000 120 10,500 28 
5,600 21 6,500 23 
400 31 200 
13,500 6,900 




The mitochondria or microsomes were heated at 100" for 10 min before incubation. 
+32P-acyl DHAP addition was omitted, instead DL-32P-a-palmitoyl GP was added. 
RESULTS 
a) Formation of alkali-stable 32 P-lipid from 32P-acyl DHAP. 
In Table 1 the conditions for the formation of alkali-stable lipid from 
acyl DHAP and DHAP are given. It is seen that the conversion of acyl DHAP to 
alkali-stable lipid is more efficient than the corresponding conversion of 
DHAP. Also, CoA is not required when acyl DHAP is used and in many instances 
CoA is actually found to be inhibitory for the reaction. This may be due to 
the formation of acyl CoA, since the addition of palmitoyl CoA was also found 
to inhibit the reaction. Long chain alcohol is needed for the reaction and 
acyl DHAP cannot be replaced by cr-acyl GP (Table 1). Addition of Mg" is 
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Table 2. Incorporation of 1-C 14 -hexadecanol into alkyl DHAP. 
The whole incubation mixture has the same composition as described under 
Table 1 except that l-Cl4 -hexadecanol (50 pg, 8.95x105 cpm) was added and no 
CoA, 32P-acyl DBAP or 32P-DBAP were present. The alkali-stable lipid was 
fractionated on a silicic acid column and alkyl-DHAP in fraction 2 was 
further purified by thin layer chromatography (see text). 
Liver mitochondria Brain microsomes 
Labeled alkyl DHAP formed 
cpm cpm 
Whole system 1,800 800 
+Palmitoyl DHAP 52,000 13,200 
(30 !Jd 
+Hexadecoxy DHAP 4,500 1,200 
+1-palmitoyl GP (DL) 2,100 750 
only slightly stimulatory, however addition of EDTA completely inhibits the 
reaction and can be reversed by the addition of Mg 
+t * 0rMn . 
b) Conversion of l-Cl4 -hexadecanol to alkyl DHAP. 
In Table 2 the data for the formation of alkyl DBAP from 1-C 
14 
-hexa- 
decanol and palmitoyl DHAP are given. Acyl GP could not replace acyl DBAP 
but a small stimulation of alkyl DBAP formation by hexadecoxy DHAP was 
observed. 
Both the 32P- and l4 C-labeled alkali-stable products were identified as 
alkyl DHAP by various methods as described previously (1). On chromatography, 
the lipid migrated with carrier alkyl DBAP in various solvents with or without 
bisulfite (10). The labeled product was stable to alkaline hydrolysis and was 
also stable to acid hydrolysis (1 N HCl, loo', 10 min) after reduction by 
NaBH4. After NaBH4 reduction the properties of the lipid became similar to 
monoalkyl GP (1). The C14-labeled lipid after treatment with LiA1H4 (11) was 
converted to C 14 -labeled chimyl alcohol which was verified by cochromatography 
with the authentic compound and also by oxidation with NaI04 and by conversion 
to the isopropylidine derivative (12). 
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cl Inhibition studies with DHAP and acyl DHAP. 
In Fig. 1A the effect of acyl DHAP on the incorporation of DHAP to alkali- 
stable lipid is shown. At a low concentration acyl DHAP was found to be some- 
what stimulatory. However, at higher concentrations, acyl DHAP, as expected, 
was inhibitory of the conversion of DHAP to alkyl ethers. DHAP, in the absence 
of CoA, did not inhibit the formation of alkali-stable lipid from acyl DHAP 
(Fig. 1B). But, in the presence of CoA, DHAP was inhibitory. This is to be 
expected since acyl DHAP formed from DHAP would lower the specific activity of 
the added radioactive precursor. 
I  I  1 
0 50 100 150 
ACYL DHAP(~M) 
B 
I  I  
0 0.5 1.0 1.5 2.0 
DHAP(mM) 
3fga l- As 
Inhibition of radioactive alkali-stable lipid formed from 
P-DHAP in brain microsomes by increasing concentrations of palmitoyl 
DHAP. The incubation condition is the same as described under Table 1 
except that 120 nmoles (3.2~10~ cpm) of 32P-DHAP was used. B. Inhibition 
of radioactive alkali-stable lipid formed from 32P-acyl DHAI-(34 nmoles, 
80,000 cpm) in brain microsomes by increasing concentrations of DHAP. The 
incubation condition is similar to that described in Table 1. Upper curve 
without CoA and lower curve with CoA. 
d) Other properties. 
Palmitic acid at low concentration (5 ugl1.2 ml) was found to stimulate 
the incorporation of DHAP to alkyl ethers. However, at higher concentrations 
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(> 20 ugl1.2 ml) palmitic acid was inhibitory. In contrast, palmitic acid at 
all concentrations was inhibitory of the conversion of acyl DHAP to alkyl DHAp. 
Free fatty acid was identified as a product of the reaction between acyl 
DHAP and long chain alcohol. Using 14 C-palmitoyl 32P-DHAP, the molar ratio of 
the long chain alcohol-dependent release of fatty acid to the amount of alkyl 
ether formed was found to be 1.1. The slight stimulation of alkyl ether forma- 
tion by the addition of alkyl DHAP (Table 2) indicated that the reaction may be 
reversible. However, in a preliminary experiment, no alkali-unstable lipid was 
found after incubating 32 P-alkyl DHAP and palmitic acid. 
DISCUSSION 
These data suggest the pathway for the formation of alkyl DHAP shown in 
Scheme 1. Endogenous fatty acid forms acyl DHAP and is again released after the 
reaction of acyl DHAP with long chain alcohol. CoA and ATP are needed for the 
acylation of DHAP. F- possibly protects the phosphomonoester bond of both 
acyl and alkyl DHAP by inhibiting lipid phosphomonoesterase (13). Mg* (or 
other metal ions) may be required for the ether bond formation. The stimula- 
tory effect of ATP on the ether bond formation from acyl DHAP is still not 











Scheme 1. Proposed pathway of biosynthesis of 1-O-alkyl dihydroxyacetone 
phosphate. 
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explained. However, the effect of ATP may not be very specific. $,y-Methylene 
adenosine triphosphate (Miles Lab., Ind.) was also found to be somewhat stimu- 
latory and only little stimulation by ATP was observed when phosphate buffer 
was used instead of Tris. The inhibition of alkyl ether biosynthesis by NADPH 
when added from the beginning of the reaction (1,14) can also be explained by 
the above scheme. Addition of NADPH would reduce the acyl DHAP to l-acyl GP 
(15), which would no longer serve as a precursor to alkyl ethers. 
The reaction is somewhat unusual in the sense that an ether bond is formed 
by replacing an ester bond. The closest analogous biochemical reaction might 
be the formation of various glycosidic linkages from phosphate esters. The 
presence of a carbonyl and an ester group adjacent to carbon-l possibly facili- 
tate the reaction with alcohol with the release of fatty acid. 
Acyl DHAP may be enzymatically reduced and acylated to form phosphatidate 
(10) or as shown here, form ether lipids which may also be reduced and 
acylated (1). Alkenyl ethers may also arise from alkyl ether lipids (16). 
Hence, the acylation of DHAP may play a key role in various aspects of cellular 
lipid metabolism. 
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